Search

everythinglearnresearchcommunity

for

Search:↓

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Imuvert can prevent some chemotherapy-induced hair loss.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

A man had bad reactions to a hair loss treatment called DNCB.

Diphlorethohydroxycarmalol may help treat hair loss better than current medications.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

The treatment was not recommended due to limited effectiveness and significant side effects.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

The salts have diverse molecular packing with significant hydrogen interactions.

New psoriasis treatments are effective but come with side effects and risks.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Alopecia is a key indicator of thallium poisoning.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

The drug combination was safe and showed promise in treating advanced tumors.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.